Cargando…
Drug Interaction and Pharmacist
The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. D...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964764/ https://www.ncbi.nlm.nih.gov/pubmed/21042495 http://dx.doi.org/10.4103/0975-1483.66807 |
_version_ | 1782189428724203520 |
---|---|
author | Ansari, JA |
author_facet | Ansari, JA |
author_sort | Ansari, JA |
collection | PubMed |
description | The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. Drugs with a narrow therapeutic range or low therapeutic index are more likely to be the objects for serious drug interactions. Object drugs in common use include warfarin, fluoroquinolones, antiepileptic drugs, oral contraceptives, cisapride, and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. The pharmacist, along with the prescriber has a duty to ensure that patients are aware of the risk of side effects and a suitable course of action should they occur. With their detailed knowledge of medicine, pharmacists have the ability to relate unexpected symptoms experienced by patients to possible adverse effects of their drug therapy. |
format | Text |
id | pubmed-2964764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-29647642010-11-01 Drug Interaction and Pharmacist Ansari, JA J Young Pharm General Pharmacy The topic of drug–drug interactions has received a great deal of recent attention from the regulatory, scientific, and health care communities worldwide. Nonsteroidal anti-inflammatory drugs, antibiotics and, in particular, rifampin are common precipitant drugs prescribed in primary care practice. Drugs with a narrow therapeutic range or low therapeutic index are more likely to be the objects for serious drug interactions. Object drugs in common use include warfarin, fluoroquinolones, antiepileptic drugs, oral contraceptives, cisapride, and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. The pharmacist, along with the prescriber has a duty to ensure that patients are aware of the risk of side effects and a suitable course of action should they occur. With their detailed knowledge of medicine, pharmacists have the ability to relate unexpected symptoms experienced by patients to possible adverse effects of their drug therapy. Medknow Publications 2010 /pmc/articles/PMC2964764/ /pubmed/21042495 http://dx.doi.org/10.4103/0975-1483.66807 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | General Pharmacy Ansari, JA Drug Interaction and Pharmacist |
title | Drug Interaction and Pharmacist |
title_full | Drug Interaction and Pharmacist |
title_fullStr | Drug Interaction and Pharmacist |
title_full_unstemmed | Drug Interaction and Pharmacist |
title_short | Drug Interaction and Pharmacist |
title_sort | drug interaction and pharmacist |
topic | General Pharmacy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964764/ https://www.ncbi.nlm.nih.gov/pubmed/21042495 http://dx.doi.org/10.4103/0975-1483.66807 |
work_keys_str_mv | AT ansarija druginteractionandpharmacist |